Michael Bretthauer
Overview
Explore the profile of Michael Bretthauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
268
Citations
3980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halvorsen N, Barua I, Kudo S, Gulati S, Misawa M, Mori K, et al.
Endoscopy
. 2025 Feb;
PMID: 40020708
No abstract available.
2.
Halvorsen N, Barua I, Kudo S, Gulati S, Misawa M, Mori K, et al.
Endoscopy
. 2025 Feb;
PMID: 39999970
Background: Computer-aided diagnosis (CADx) enables the distinction between neoplastic and non-neoplastic polyps during colonoscopy. We aimed to estimate the patient-level benefit and harm of CADx. Methods: We conducted a comparative...
3.
4.
Pilonis N, Spychalski P, Kalager M, Loberg M, Wieszczy P, Didkowska J, et al.
JAMA
. 2024 Dec;
333(5):400-407.
PMID: 39680377
Importance: Patients of physicians with higher adenoma detection rates (ADRs) during colonoscopy have lower colorectal cancer (CRC) risk after screening colonoscopy (ie, postcolonoscopy CRC). Among physicians with an ADR above...
5.
6.
Antonelli G, Libanio D, de Groof A, van der Sommen F, Mascagni P, Sinonquel P, et al.
Gut
. 2024 Oct;
74(1):153-161.
PMID: 39406471
Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and...
7.
Martinez-Roca A, Cubiella J, Garcia-Heredia A, Guill-Berbegal D, Baile-Maxia S, Mangas-Sanjuan C, et al.
United European Gastroenterol J
. 2024 Oct;
12(9):1179-1189.
PMID: 39400528
Background: The potential of molecular markers in the removed polys as reliable predictors of metachronous lesions is still uncertain. Aim: Our aim was to evaluate the role of somatic mutations...
8.
Rognstad O, Botteri E, Hoff G, Bretthauer M, Gulichsen E, Frigstad S, et al.
BMJ Open Gastroenterol
. 2024 Oct;
11(1).
PMID: 39375173
Objective: Colonoscopy-related adverse events increase the burden of colorectal cancer (CRC) screening. This cross-sectional study evaluates adverse events during and after colonoscopy in a large, randomised CRC screening trial in...
9.
Randel K, Botteri E, de Lange T, Schult A, Eskeland S, El-Safadi B, et al.
Aliment Pharmacol Ther
. 2024 Oct;
61(1):122-131.
PMID: 39373173
Background: The positivity thresholds of faecal immunochemical testing (FIT) in colorectal cancer (CRC) screening vary between countries. Aims: To explore the trade-off between colonoscopies performed, adverse events and lesions detected...
10.
Nilsen J, Bernklev L, Bretthauer M, Kalager M, Jodal H, Loberg M, et al.
Tidsskr Nor Laegeforen
. 2024 Sep;
144(10).
PMID: 39254026
Background: Colorectal cancer is one of the most common forms of cancer in Norway, and typically develops from colorectal polyps. For benign colorectal polyps, endoscopic removal is recommended to avoid...